- Pool Corp (NASDAQ:POOL) reported fourth-quarter FY22 sales growth of 6% year-on-year to $1.09 billion, missing the consensus of $1.15 billion.
- Base business net sales increased 1%. Net sales benefited 8% from inflationary product cost increases versus 10% last year.
- Gross profit decreased 2% Y/Y to $315.7 million, while gross margin contracted 230 basis points Y/Y to 28.8%.
- EPS was $1.82 versus $2.65 a year ago, while adjusted EPS was $1.79 against $2.30 prior year.
- Selling and administrative expenses rose 7.2% Y/Y to $208.4 million.
- Operating margin contracted 250 basis points to 9.8%, and the operating income for the quarter fell 16% to $107.3 million.
- Cash and equivalents totaled $45.6 million as of Dec 31, 2022. Net cash provided by operating activities for the year grew to $484.8 million from $313.49 million a year ago.
- Adjusted EBITDA for the year was $1.07 billion, an increase of 23.4% Y/Y.
- Outlook: Pool sees FY23 2023 EPS of $16.03 – $17.03, including an estimated $0.03 tax benefit. It sees Adjusted EPS of $16.00-$17.00.
- Price Action: POOL shares are trading higher by 2.02% at $392.33 on the last check Thursday.
Jim Cramer Sees Eli Lilly As More Than A ‘One-Trick Pony’ After FDA Advisors Back Its Alzheimer’s Drug: ‘It’s Ultimately Headed To A Trillion Dollar Valuation’
Jim Cramer has expressed his confidence in Eli Lilly and Co, citing the company's diverse drug portfolio and the recent endorsement of its Alzheimer's treatment by FDA advisors.
